The myokine Fibcd1 is an endogenous determinant of myofiber size and mitigates cancer-induced myofiber atrophy
Myofiber atrophy occurs in many diseases but the mechanisms responsible for myofiber size determination are incompletely understood. Here, the authors show that the muscle-secreted factor Fibcd1 is necessary to maintain myofiber size and mitigates myofiber atrophy induced by cancer cachexia
Main Authors: | Flavia A. Graca, Mamta Rai, Liam C. Hunt, Anna Stephan, Yong-Dong Wang, Brittney Gordon, Ruishan Wang, Giovanni Quarato, Beisi Xu, Yiping Fan, Myriam Labelle, Fabio Demontis |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-30120-1 |
Similar Items
-
A Key Role for the Ubiquitin Ligase UBR4 in Myofiber Hypertrophy in Drosophila and Mice
by: Liam C. Hunt, et al.
Published: (2019-07-01) -
A large-scale transgenic RNAi screen identifies transcription factors that modulate myofiber size in Drosophila.
by: Flavia A Graca, et al.
Published: (2021-11-01) -
Analysis of potential regulatory LncRNAs and CircRNAs in the oxidative myofiber and glycolytic myofiber of chickens
by: Xiaojun Ju, et al.
Published: (2021-10-01) -
Lunar gravity prevents skeletal muscle atrophy but not myofiber type shift in mice
by: Takuto Hayashi, et al.
Published: (2023-04-01) -
Leiomodin-3-deficient mice display nemaline myopathy with fast-myofiber atrophy
by: Lei Tian, et al.
Published: (2015-06-01)